| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |